Stocks · Health care · Biological Products, (No Diagnostic Substances)

C4 Therapeutics, Inc.

CCCC Clue Score37
United States Fiscal year ends December CIK 0001662579 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

10 insiders · 0 transactions
3.4×

Andrew J. Hirsch holds only 3.4 times base salary in stock. $2.39M of shares against $694.93K in salary for 2025.

Salary from the company's own proxy. The shares are what Andrew J. Hirsch last reported holding, valued at $2.22, the price Common Stock was last bought or sold at on the open market here, on 16 Jan 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Andrew Hirsch
President & CEO
—
—
—
1,074,934
$2.39M
+853.1%
Kendra Adams
Chief Financial Officer
—
—
—
382,323
$848.76K
+1,005%
Leonard Reyno
Chief Medical Officer
—
—
—
372,406
$826.74K
+717.9%
Kenneth Carl Anderson
Director
—
—
—
361,897
$803.41K
+12.9%
Paige Mahaney
Chief Scientific Officer
—
—
—
336,910
$747.94K
+566.5%
Kelly Schick
Chief People Officer
—
—
—
299,881
$665.74K
+975.2%
Scott N Boyle
Chief Business Officer
—
—
—
298,801
$663.34K
+968.3%
Jolie Siegel
Chief Legal Officer
—
—
—
107,939
$239.62K
+100.5%
Donna Roy Grogan
Director
—
—
—
79,471
$176.43K
+174.6%
Mark Mossler
Chief Accounting Officer
—
—
—
71,916
$159.65K
+593.5%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.